![](/img/cover-not-exists.png)
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer
Rugo, Hope S., Campone, Mario, Amadori, Dino, Aldrighetti, Daniela, Conte, PierFranco, Wardley, Andrew, Villanueva, Cristian, Melisko, Michelle, McHenry, M. Brent, Liu, David, Lee, Francis, Pivot, XavVolume:
139
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-013-2552-8
Date:
June, 2013
File:
PDF, 333 KB
english, 2013